Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	Treatment
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.0428	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.0428	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.0564	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.4501	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.4790	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.8747	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.8825	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	0.9547	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.0453	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.0465	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.1767	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.4515	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	1.7341	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	2.0203	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxyphenylacetate	2.8390	Peak area	Feces	Saline